Crossmark

Endosomal chloride/proton exchangers need inhibitory TMEM9 β-subunits for regulation and prevention of disease-causing overactivity

Crossref DOI link: https://doi.org/10.1038/s41467-025-58546-3

Published Online: 2025-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Planells-Cases, Rosa https://orcid.org/0000-0002-9841-8434
Vorobeva, Viktoriia https://orcid.org/0009-0004-1977-2120
Kar, Sumanta https://orcid.org/0000-0002-3368-8986
Schmitt, Franziska W. https://orcid.org/0000-0002-6878-6084
Schulte, Uwe https://orcid.org/0000-0003-3557-0591
Schrecker, Marina

Hite, Richard K. https://orcid.org/0000-0003-0496-0669
Fakler, Bernd https://orcid.org/0000-0001-7264-6423
Jentsch, Thomas J. https://orcid.org/0000-0002-3509-2553
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

Received: 10 December 2024

Accepted: 20 March 2025

First Online: 1 April 2025

Competing interests

: R.H. is a consultant for F. Hoffmann-La Roche Ltd. The remaining authors declare no competing interests.